Joanne K. Daggy

Dr. Joanne K. Daggy

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2014 in Cancer
Verified
Journal Article
Open access
PDF file
VCVictoria L Champion
Victoria L Champion
LWLynne I. Wagner
Lynne I. Wagner
PMPatrick O. Monahan
Patrick O. Monahan
Joanne K. DaggyJoanne K. Daggy
Joanne K. Daggy
LSLisa Smith
Lisa Smith
GSGeorge W. Sledge
George W. Sledge
BACKGROUND: Younger survivors (YS) of breast cancer often report more survivorship symptoms such as fatigue, depression, sexual difficulty, and cognitive problems than older survivors (OS). This study sought to determine the effect of breast cancer and age at diagnosis on quality of life (QoL) by comparing 3 groups: 1) YS diagnosed at age 45 years or before, 2) OS diagnosed between 55 and 70, and 3) for the YSs, age‐matched controls (AC) of women not diagnosed with breast cancer.METHODS: Using a large Eastern Cooperative Oncology Group (ECOG) database, 505 YS were recruited who were aged 45 years or younger when diagnosed and 622 OS diagnosed at 55 to 70 years of age. YS, OS, and AC were compared on physical, psychological, social, spiritual, and overall QoL variables.RESULTS: Compared to both AC and to OS, YS reported more depressive symptoms (P = .005) and fatigue (P < .001), poorer self‐reported attention function (P < .001), and poorer sexual function (P < .001) than either comparison group. However, YS also reported a greater sense of personal growth (P < .001) and perceived less social constraint (P < .001) from their partner than AC.CONCLUSIONS: YS reported worse functioning than AC relative to depression, fatigue, attention, sexual function, and spirituality. Perhaps even more important, YS fared worse than both AC and OS on body image, anxiety, sleep, marital satisfaction, and fear of recurrence, indicating that YS are at greater risk for long‐term QoL problems than survivors diagnosed at a later age.Cancer2014;120:2237–2246.©2014 American Cancer Society.

1 November 2004 in Journal of Health Psychology
Verified
Journal Article
Closed access
PDF file
VCVictoria L Champion
Victoria L Champion
CSCelette Sugg Skinner
Celette Sugg Skinner
UMUsha Menon
Usha Menon
SRSusan Rawl
Susan Rawl
RGR. Brian Giesler
R. Brian Giesler
Joanne K. DaggyJoanne K. Daggy
Joanne K. Daggy
Fear of breast cancer has been inversely associated with participation in screening. However, investigators have generally used only one item or global scales to measure fear. This report describes development of a fear scale specific to breast cancer. Data from a large study involving mammography adherence were used to test the breast cancer fear scale for validity and reliability. Construct validity was verified through factor analysis and regression analysis predicting mammography. All items loaded on a single factor and theoretical relationships were verified by linear and logistic regression. The Cronbach alpha for the scale was .91.

1 December 2010 in Health Informatics Journal
Verified
Journal Article
Closed access
Joanne K. DaggyJoanne K. Daggy
Joanne K. Daggy
MLMark Lawley
Mark Lawley
DWDeanna Willis
Deanna Willis
DTDebra Thayer
Debra Thayer
CSChristopher Suelzer
Christopher Suelzer
LSLaura Sands
Laura Sands
‘No-shows’ or missed appointments result in under-utilized clinic capacity. We develop a logistic regression model using electronic medical records to estimate patients’ no-show probabilities and illustrate the use of the estimates in creating clinic schedules that maximize clinic capacity utilization while maintaining small patient waiting times and clinic overtime costs. This study used information on scheduled outpatient appointments collected over a three-year period at a Veterans Affairs medical center. The call-in process for 400 clinic days was simulated and for each day two schedules were created: the traditional method that assigned one patient per appointment slot, and the proposed method that scheduled patients according to their no-show probability to balance patient waiting, overtime and revenue. Combining patient no-show models with advanced scheduling methods would allow more patients to be seen a day while improving clinic efficiency. Clinics should consider the benefits of implementing scheduling software that includes these methods relative to the cost of no-shows.

23 June 2005 in Cancer
Verified
Journal Article
Closed access
PDF file
JWJeffrey D. Wagner
Jeffrey D. Wagner
DSDonald Schauwecker
Donald Schauwecker
DDDarrell Davidson
Darrell Davidson
TLTheodore Logan
Theodore Logan
JCJohn J. Coleman
John J. Coleman
Joanne K. DaggyJoanne K. Daggy
Joanne K. Daggy

25 March 2014 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
ARAlissa L Russ
Alissa L Russ
AZAlan J Zillich
Alan J Zillich
BMBrittany L Melton
Brittany L Melton
SRScott A Russell
Scott A Russell
SCSiying Chen
Siying Chen
JSJason J Saleem
Jason J Saleem
Objective To apply human factors engineering principles to improve alert interface design. We hypothesized that incorporating human factors principles

1 May 2005 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
Liang ChengLiang Cheng
Liang Cheng
MKMichael O. Koch
Michael O. Koch
BJBeth E. Juliar
Beth E. Juliar
Joanne K. DaggyJoanne K. Daggy
Joanne K. Daggy
RFRichard S. Foster
Richard S. Foster
TGThomas A. Gardner
Thomas A. Gardner
Purpose: Clinical outcome is variable in prostate cancer patients treated with radical prostatectomy. The Gleason histologic grade of prostatic adenocarcinoma is one of the strongest predictors of biologic aggressiveness of prostate cancer. We evaluated the significance of the relative proportion of high-grade cancer (Gleason patterns 4 and/or 5) in predicting cancer progression in prostate cancer patients treated with radical prostatectomy. Patients and Methods: Radical prostatectomy specimens from 364 consecutive prostate cancer patients were totally embedded and whole mounted. Various clinical and pathologic characteristics were analyzed. All pathologic data, including Gleason grading variables, were collected prospectively. Results: A multiple-factor analysis was performed that included the combined percentage of Gleason patterns 4 and 5, Gleason score, tumor stage, surgical margin status, preoperative prostate-specific antigen (PSA), extraprostatic extension, and total tumor volume. Using Cox regression analysis with bootstrap resampling for predictor selection, we identified the combined percentage of Gleason patterns 4 and 5 (P < .0001) and total tumor volume (P = .009) as significant predictors of PSA recurrence. Conclusion: The combined percentage of Gleason patterns 4 and 5 is one of the most powerful predictors of patient outcome, and appears superior to conventional Gleason score in identifying patients at increased risk of disease progression. On the basis of our results, we recommend that the combined percentage of Gleason patterns 4 and 5 be evaluated in radical prostatectomy specimens. The amount of high-grade cancer in a prostatectomy specimen should be taken into account in therapeutic decision making and assessment of patient prognosis.